{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:13:03Z","timestamp":1761516783547,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.4158\/ep-2018-0386","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T15:47:07Z","timestamp":1541087227000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A 2017 Survey of the Clinical Practice Patterns in the Management of Relapsing Graves Disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Shlomit","family":"Koren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Shteinshnaider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dror","family":"Cantrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Benbassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronit","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0386_bb0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0386_bb0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/thy.2015.0277","article-title":"Development and pilot testing of an encounter tool for shared decision making about the treatment of Graves' disease","volume":"25","author":"Brito","year":"2015","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0386_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0029-1211072","article-title":"Differences and similarities in the treatment of diffuse goiter in Europe and the United States","volume":"97","author":"Wartofsky","year":"1991","journal-title":"Exp Clin Endocrinol"},{"key":"10.4158\/EP-2018-0386_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4158\/EP-2017-0266","article-title":"The trends of hyperthyroidism treatment in Taiwan: a nationwide population-based study","volume":"24","author":"Kornelius","year":"2018","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0386_bb0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves' disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"key":"10.4158\/EP-2018-0386_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/pmj.76.896.340","article-title":"Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years","volume":"76","author":"Escobar-Jim\u00e9nez","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.4158\/EP-2018-0386_bb0040","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves' disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0386_bb0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444482","article-title":"A 2015 Italian survey of clinical practice patterns in the management of Graves' disease: comparison with European and North American surveys","volume":"5","author":"Negro","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.4158\/EP-2018-0386_bb0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4158\/EP161607.OR","article-title":"A survey of clinical practice patterns in management of Graves disease in the Middle East and North Africa","volume":"23","author":"Beshyah","year":"2017","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2018-0386_bb0055","first-page":"10","article-title":"The management of Graves' disease in New Zealand 2014","volume":"129","author":"Cox","year":"2016","journal-title":"N Z Med J"},{"key":"10.4158\/EP-2018-0386_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000453260","article-title":"Survey of clinical practice patterns in the management of 992 hyperthyroid patients in France","volume":"6","author":"Goichot","year":"2017","journal-title":"Eur Thyroid J"},{"key":"10.4158\/EP-2018-0386_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves' disease","volume":"84","author":"Bartalena","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0386_bb0070","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/14740338.2014.953796","article-title":"Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity","volume":"13","author":"Akmal","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.4158\/EP-2018-0386_bb0075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0386_bb0080","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0386_bb0085","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis","volume":"98","author":"Sundaresh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0386_bb0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0386_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2018-0386_bb0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1089\/thy.2017.0251","article-title":"First Israeli national iodine survey demonstrates iodine deficiency among school-aged children and pregnant women","volume":"27","author":"Ovadia","year":"2017","journal-title":"Thyroid"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:06Z","timestamp":1761516426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1530891X20359449"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0386","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 2017 Survey of the Clinical Practice Patterns in the Management of Relapsing Graves Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}